Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
49,834,317
-
Share change
-
+6,447,274
-
Total reported value
-
$2,407,032,328
-
Put/Call ratio
-
60%
-
Price per share
-
$48.30
-
Number of holders
-
172
-
Value change
-
+$327,784,015
-
Number of buys
-
106
-
Number of sells
-
78
Institutional Holders of GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) as of Q1 2018
As of 31 Mar 2018,
GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) was held by
172 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,834,317 shares.
The largest 10 holders included
FMR LLC, PERCEPTIVE ADVISORS LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, venBio Select Advisor LLC, and ORBIMED ADVISORS LLC.
This page lists
172
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.